Decreased expression of miR-542-3p exerts growth inhibitory functions in esophageal cancer

Bei-Bei Chen, Xiao-Bing Chen, Liang-Yu Bie

  • 1Department of Medical Gastroenterology, Cancer Hospital of Henan Province, The Affiliated Cancer Hospital of Zhengzhou University, Henan 450008, PR China.

Abstract

Insights

MicroRNA-542-3p (miR-542-3p) acts as a tumor suppressor in esophageal squamous cell carcinoma (ESCC). Its decreased expression correlates with tumor grade, and restoring miR-542-3p levels inhibits cancer cell proliferation.

Area of Science:

  • Molecular biology
  • Oncology
  • Biochemistry

Background:

  • MicroRNAs (miRNAs) are short non-coding RNAs regulating gene expression.
  • Identifying novel biomarkers is crucial for cancer therapeutics.
  • The role of miR-542-3p in esophageal squamous cell carcinoma (ESCC) was investigated.

Purpose of the Study:

  • To characterize the expression and function of miR-542-3p in ESCC.
  • To determine if miR-542-3p acts as a tumor suppressor in ESCC.
  • To explore the association between miR-542-3p expression and clinical characteristics.

Main Methods:

  • Real-time PCR to quantify miR-542-3p expression.
  • Transfection with miR-542-3p mimics or inhibitors.
  • Cell counting assays to assess cell proliferation.
  • Statistical analysis of expression and clinical data.

Main Results:

  • miR-542-3p expression was significantly decreased in ESCC tissues and cell lines.
  • Downregulation of miR-542-3p correlated with higher tumor grade.
  • Forced expression of miR-542-3p suppressed cell proliferation.
  • Inhibition of miR-542-3p enhanced cell growth rate.

Conclusions:

  • miR-542-3p functions as a tumor suppressor in esophageal cancer.
  • miR-542-3p regulates critical steps in cell growth.
  • miR-542-3p represents a potential therapeutic target for ESCC.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.7K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.3K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.4K
Barrett Esophagus-II: Clinical Manifestations and Management01:21

Barrett Esophagus-II: Clinical Manifestations and Management

Individuals with Barrett's esophagus are often asymptomatic, but they may experience symptoms commonly associated with GERD, such as heartburn and acid regurgitation. Additional symptoms can include difficulty swallowing, chest pain, unintentional weight loss, blood in the stool (which may appear black, tarry, or bloody), and episodes of vomiting.
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
1.5K
Esophageal Strictures-I: Introduction01:30

Esophageal Strictures-I: Introduction

Esophageal strictures involve abnormal narrowing or tightening of the esophagus. They vary in length and severity, ranging from mild constriction to complete obstruction, and are classified as benign (noncancerous) or malignant (cancerous).
Etiology
The primary cause of esophageal strictures is long-standing gastroesophageal reflux disease (GERD), accounting for about 70 to 80% of adult cases. Chronic acid reflux can lead to injury and scarring of the esophageal lining, culminating in...
1.2K